Skip to main content
Equibles
IMVT logo

IMVT · Immunovant, Inc. · Analyst Estimates

Track IMVT — free

Use IMVT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research IMVT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$28.88 +0.71 (+2.52%) At close · Oct 27 Q3 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$5.82B
Shares
206.55M
Volume · Oct 27 1.06M Avg daily vol (3M) 1.34M

Analyst Estimates

Compare analyst forecasts for Immunovant, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-29 23:23 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2027-03-31

Analyst estimates for FY ending 2027-03-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-3.05
-2.84
-2.52
5
-2.84
-2.84
-2.58
-2.52
0
3
0
0
Revenue
USD
Publication date not stated
0.00
0.00
0.00
13
 — — — — — — — —

FY ending 2028-03-31

Analyst estimates for FY ending 2028-03-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-3.21
-2.75
-2.38
5
-2.50
-2.22
-2.50
-2.40
1
3
0
0
Revenue
USD
Publication date not stated
0.00
36.81M
206.45M
14
 — — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.76
-0.72
-0.70
3
-0.73
-0.53
-0.53
-0.53
0
1
0
0
Revenue
USD
Publication date not stated
0.00
0.00
0.00
12
 — — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.77
-0.67
-0.53
3
-0.74
-0.45
-0.45
-0.45
0
1
0
0
Revenue
USD
Publication date not stated
0.00
0.00
0.00
12
 — — — — — — — —
Key facts CIK 1764013 CUSIP 45258J102 13F (30d) 24 filings 24 filers Visit website Investor relations